Given the volatility associated with the industry, when picking biotech stocks it may make sense to look to the best for ideas – and when it comes to the biotech space, brothers Julian and Felix Baker – and the biotech-focused hedge fund they founded – have proven themselves to be among the best. As a result, the author of today’s article scanned the fund’s recent 13F filing for ideas, and she highlights three particular small-cap biotech stocks sporting “Buy” ratings and impressive upside potential. For more, CLICK HERE.